Psychotropic Taxonomies: Constructing a Therapeutic Framework for Psychiatry

Area of Science:

• Psychiatry
• Pharmacology
• Neuroscience

Background:

• Pharmacological interventions are central to psychiatric practice.
• Existing disease-based drug classifications (e.g., antidepressants, antipsychotics) inadequately represent the transdiagnostic use of psychotropic agents and the dimensional nature of psychiatric illness.
• Current taxonomies impact treatment strategies and the interpretation of psychiatric symptoms.

Purpose of the Study:

• To review the historical evolution of psychotropic drug classification systems.
• To analyze the influence of these taxonomies on clinical practice and pharmaceutical development.
• To propose data-driven approaches for a more nuanced classification of psychiatric medications.

Main Methods:

• Literature review of historical and contemporary psychotropic drug taxonomies.
• Analysis of the impact of classification systems on clinical practice and drug development.
• Exploration of data-driven methodologies for future classification frameworks.

Main Results:

• Disease-based classification systems are insufficient for modern psychiatric practice.
• Psychotropic drug taxonomies exist on a spectrum from broad disease categories to specific molecular targets.
• Data-driven methods offer potential for intermediate classification levels based on transdiagnostic markers.

Conclusions:

• Rethinking psychotropic drug classification is crucial for advancing psychiatric treatment and research.
• A shift towards understanding drug actions based on neurobiological and psychopathological markers is warranted.
• Future classification systems may leverage data-driven approaches for improved precision in psychiatric pharmacotherapy.